- Home
- ZG vs ABVX Comparison
ZG vs ABVX Comparison
Compare ZG & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZG | ABVX |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | France |
| Employees | 7068 | 69 |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 7.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ZG | ABVX |
|---|---|---|
| Price | $32.63 | $99.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 13 |
| Target Price | $78.68 | ★ $131.31 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 05-06-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.77 | $52.14 |
| Revenue Next Year | $13.31 | $4,132.27 |
| P/E Ratio | $499.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.72 | $7.41 |
| 52 Week High | $90.22 | $148.83 |
Technical Indicators
Market Signals| Indicator | ZG | ABVX |
|---|---|---|
| Relative Strength Index (RSI) | 33.28 | 43.82 |
| Support Level | N/A | $87.60 |
| Resistance Level | $47.34 | $131.50 |
| Average True Range (ATR) | 1.76 | 7.75 |
| MACD | -0.04 | -0.43 |
| Stochastic Oscillator | 13.63 | 46.23 |
Price Performance
Historical ComparisonAbout ZG Zillow Group Inc.
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.